Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Medical team successfully delivers baby and removes massive tumor - 2Nutrient Rich Natural products: Lift Your Wellbeing
- 3Extraordinary Shows to Long distance race on a Plane
- 4Hanwha Ocean secures orders worth $866m for five vessels
- 5Sean 'Diddy' Combs faces new sexual assault allegations, currently under investigation by Los Angeles Sheriff's Department
- From Dread to Certainty: Individual Accounts of Strengthening
- Instructions to Back Your Sunlight powered chargers: Tracking down Possible Choices
- Ukraine confirms defence and energy ministers at second attempt
- 'Stranger Things' character guide: The nerds, the newcomers and the rest of the Season 5 cast
- When Would it be a good idea for you to Look for Help from a Criminal Legal counselor?
- Do you lean your seat back on the plane? These travel pros — and real-life couple — won't do it.
- Solar storms have influenced our history – an environmental historian explains how they could also threaten our future
- A Colombian city swaps iconic horse buggies for electric carriages amid animal welfare concerns
- Satellite space quiz: What's orbiting Earth?
